Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
Thermage to buy Reliant for $87.5 million plus debt
New York - Thermage, which makes an anti-aging skin tightening device, announced it will buy Reliant Technologies for $87.5 million in stock and cash, according to the Associated Press.
New York
- Thermage, which makes an anti-aging skin tightening device, announced it will buy Reliant Technologies for $87.5 million in stock and cash, according to the Associated Press.
Thermage is set to pay $25 million in cash and issue $23.6 million shares valued at $62.5 million. Thermage also agreed to assume $7 million in debt and provide $5 million of bridge financing to Reliant.
Related Videos
Related Content
